Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Thermoplastic fluoropolymer composition
String changing tool with a quick connector assembly and worm gear string cutter
Method to prevent hyper frame number de-synchronization in a wireless communication system
Integrated circuit packaging system with an integral-interposer-structure and method of manufacture thereof
Emergency whistle, flashlight, and compass
Analogue-to-digital converter
Receiver and transmitter receiver system
  Randomly Featured Patents
Open-circuit shunt-regulated high-voltage circuit
Automotive vehicle with improved suspension system
Method and apparatus for fast response and distortion measurement
Vehicle window glass antenna
Method for preparing improved porous metal-hydride compacts
Cosmetic composition with anti-free radical activity
Hydrosilylation method
System and method for stimulating a heart having undergone cardiac myoplasty using a single-chamber pacemaker
Method for monitoring and managing operational characteristics of workstations on a network without user network impact
Adhesive abrasion-resistant protective hoof coating